Patent details

Basic Information

Publication number:

EP2792662

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP141731901

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Morphinan compounds

French Title of Invention:

Composés de morphinane

German Title of Invention:

Morphinanverbindungen

SPC Number:

Dates

Filing date:

30/04/2008

Grant date:

06/04/2016

EP Publication Date:

06/04/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/10/2014

EP B1 Publication Date:

06/04/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

30/04/2018

Expiration date:

30/04/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

30/04/2008

 

 

Name:

Concert Pharmaceuticals Inc.

Address:

99 Hayden Avenue, Lexington, MA 02421, United States (US)

Agent

Name:

MARKS & CLERK LLP

From:

10/05/2016

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

Name:

Tung Roger

Address:

United States (US)

Priority

1

Priority Number:

915130 P

Priority Date:

01/05/2007

Priority Country:

United States (US)

2

Priority Number:

916662 P

Priority Date:

08/05/2007

Priority Country:

United States (US)

3

Priority Number:

976044 P

Priority Date:

28/09/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

C07B 59/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

26/04/2017

Last Annual Fee Paid Number:

10

Last Annual Fee Paid Amount:

131 Euro

Payer:

OFFICE FREYLINGER S.A.

Filing date	Document type	Number of pages
30/08/2018	Outgoing Correspondence	1
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56